Identification of TIE2 as a susceptibility gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathyZhen Ji Chen, Li Ma, Marten E Brelen, Haoyu Chen, Motokazu Tsujikawa, Timothy Y Lai, Mary Ho, Kaori Sayanagi, Chikako Hara, Noriyasu Hashida, Pancy OS Tam, Alvin L Young, Kohji Nishida, Clement C Tham, Chi Pui PangSee the full list of authors
9 March 2020
ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD)Sandra Liakopoulos, Georg Spital, Christian K Brinkmann, Tina Schick, Focke Ziemssen, Jessica Voegeler, Mirja Koch, Bernd Kirchhof, Frank G Holz, Daniel Pauleikhoff, Steffen Schmitz-Valckenberg
17 February 2020
Comparison of OCT angiography in children with a history of intravitreal injection of ranibizumab versus laser photocoagulation for retinopathy of prematurityJinfeng Zhao, Zhenquan Wu, Waiching Lam, Mingmin Yang, Lu Chen, Lei Zheng, Fuyan Zhang, Jian Zeng, Jiantao Wang, Guoming Zhang
12 February 2020
Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosaStacey A Strong, Tunde Peto, Catey Bunce, Wen Xing, Michalis Georgiou, Simona Degli Esposti, Angelos Kalitzeos, Andrew Webster, Michel Michaelides
10 February 2020
Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathyHan Joo Cho, Kunhae Kim, Soo Hyun Lim, Dong Hyun Kang, Jong Woo Kim
2 January 2020
Higher aqueous levels of matrix metalloproteinases indicated visual impairment in patients with retina vein occlusion after anti-VEGF therapyYong Luo, Jianbo Wan, Chang Luo, HengWei Liu, YuFan Zhou, Heping Xu, Zhongping Chen
16 December 2019
Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! projectVincent Daien, Vuong Nguyen, Rohan W Essex, Robin Guymer, Jennifer J Arnold, Marion Munk, Lala Ceklic, Mark C Gillies, Daniel Barthelmes
16 December 2019
Changes in neovascular activity following fixed dosing with an anti-vascular endothelial growth factor agent over 52 weeks in the phase III VIEW 1 and VIEW 2 studiesDarius M Moshfeghi, Desmond Thompson, Namrata Saroj
11 December 2019
Non-proliferative type II macular telangiectasia variant with subfoveal detachment: role of anti-VEGF therapyGeorge J Manayath, Ratnesh Ranjan, C K Nagesha, Venkatapathy Narendran
2 December 2019
Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME studyMasahiko Shimura, Shigehiko Kitano, Daisuke Muramatsu, Harumi Fukushima, Yoshihiro Takamura, Makiko Matsumoto, Masahide Kokado, Jiro Kogo, Mariko Sasaki, Yuki Morizane, Osamu Kotake, Takashi Koto, Shozo Sonoda, Takao Hirano, Hiroto IshikawaSee the full list of authors
29 November 2019
